FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200121631> ?p ?o ?g. }

• W4200121631 endingPage "318" @default.
• W4200121631 startingPage "311" @default.
• W4200121631 abstract "Oxaliplatin utilized in colorectal neoplasms treatment could induce acute peripheral neuropathy (APN) which is a dreadful and frequent adverse event. The objective of this study is to estimate incidence of APN induced by oxaliplatin cumulative incidence in cancer patients colorectal and to describe the distribution of the APN incidence according to demographic and clinical characteristics, as well as according to oxaliplatin cumulative dose.This is a prospective descriptive study which took place from June to December 2018 at the Salah Azaiz Institute, Tunis. Demographic data, clinical data and data on oxaliplatin administration were collected from patient interview, medical files and pharmaceutical databases.The APN (grade 1, grade 2 and grade 3) cumulative incidence during the period of six months of follow up was 86% (95% CI [0.7815-0.9132]). While 38.3% (95% CI [0.29-0.48]) of the patients had grade 2 or 3 neuropathy. The search for factors associated with the risk of grade 2 and 3 NAP revealed trend significant association with diabetes (adjusted RR = 5.7 (IC95% [0.9- 37.3]; p = 0.07). Moreover, there was significant association with oxaliplatin cumulative dose (≥421 mg/m2) to increase the risk of APN grade 2 and 3 (adjusted RR = 7.8; [2.7-22.7]; p = 0.0001). Furthermore, significant association with obesity to increase the risk of APN grade 2 and 3 (adjusted RR = 5.3 [1.1- 25.4]; p = 0.04) was found. Among the patients included, 31.1% experienced oxaliplatin dose reduction and in the majority of cases this reduction is due to neurotoxicity (90.9%).The high incidence of oxaliplatin-induced APN remains an embarrassing and handicapping side effect. Our study has shown that oxaliplatin cumulative dose (≥421 mg/m2), diabetes and obesity are risk factor for the development of grade 2 and 3 APN." @default.
• W4200121631 created "2021-12-31" @default.
• W4200121631 creator A5018778965 @default.
• W4200121631 creator A5028840974 @default.
• W4200121631 creator A5039904590 @default.
• W4200121631 creator A5052846445 @default.
• W4200121631 creator A5060189852 @default.
• W4200121631 creator A5066794585 @default.
• W4200121631 creator A5069905338 @default.
• W4200121631 creator A5088808465 @default.
• W4200121631 date "2021-12-17" @default.
• W4200121631 modified "2023-10-09" @default.
• W4200121631 title "Incidence and risk factors associated with development of oxalipatin-induced acute peripheral neuropathy in colorectal cancer patients" @default.
• W4200121631 cites W1519813906 @default.
• W4200121631 cites W1757407923 @default.
• W4200121631 cites W1966950736 @default.
• W4200121631 cites W1968626722 @default.
• W4200121631 cites W1992768230 @default.
• W4200121631 cites W2006004215 @default.
• W4200121631 cites W2008217792 @default.
• W4200121631 cites W2010886350 @default.
• W4200121631 cites W2120713475 @default.
• W4200121631 cites W2121368761 @default.
• W4200121631 cites W2128519670 @default.
• W4200121631 cites W2129184772 @default.
• W4200121631 cites W2131661945 @default.
• W4200121631 cites W2136984368 @default.
• W4200121631 cites W2138474390 @default.
• W4200121631 cites W2151693072 @default.
• W4200121631 cites W2163024772 @default.
• W4200121631 cites W2167989630 @default.
• W4200121631 cites W2227054308 @default.
• W4200121631 cites W2729298813 @default.
• W4200121631 cites W2737110054 @default.
• W4200121631 cites W2765914354 @default.
• W4200121631 cites W2901219667 @default.
• W4200121631 cites W2904417050 @default.
• W4200121631 cites W2908885417 @default.
• W4200121631 cites W2923287877 @default.
• W4200121631 cites W3010157692 @default.
• W4200121631 cites W3010712807 @default.
• W4200121631 cites W3031556409 @default.
• W4200121631 cites W3032409954 @default.
• W4200121631 cites W3167238817 @default.
• W4200121631 cites W3207717469 @default.
• W4200121631 cites W3210338691 @default.
• W4200121631 cites W4242872483 @default.
• W4200121631 doi "https://doi.org/10.1177/10781552211068138" @default.
• W4200121631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34918549" @default.
• W4200121631 hasPublicationYear "2021" @default.
• W4200121631 type Work @default.
• W4200121631 citedByCount "2" @default.
• W4200121631 countsByYear W42001216312023 @default.
• W4200121631 crossrefType "journal-article" @default.
• W4200121631 hasAuthorship W4200121631A5018778965 @default.
• W4200121631 hasAuthorship W4200121631A5028840974 @default.
• W4200121631 hasAuthorship W4200121631A5039904590 @default.
• W4200121631 hasAuthorship W4200121631A5052846445 @default.
• W4200121631 hasAuthorship W4200121631A5060189852 @default.
• W4200121631 hasAuthorship W4200121631A5066794585 @default.
• W4200121631 hasAuthorship W4200121631A5069905338 @default.
• W4200121631 hasAuthorship W4200121631A5088808465 @default.
• W4200121631 hasConcept C120665830 @default.
• W4200121631 hasConcept C121332964 @default.
• W4200121631 hasConcept C121608353 @default.
• W4200121631 hasConcept C126322002 @default.
• W4200121631 hasConcept C134018914 @default.
• W4200121631 hasConcept C151032500 @default.
• W4200121631 hasConcept C188816634 @default.
• W4200121631 hasConcept C2779901536 @default.
• W4200121631 hasConcept C2780962732 @default.
• W4200121631 hasConcept C44249647 @default.
• W4200121631 hasConcept C526805850 @default.
• W4200121631 hasConcept C555293320 @default.
• W4200121631 hasConcept C61511704 @default.
• W4200121631 hasConcept C71924100 @default.
• W4200121631 hasConcept C72563966 @default.
• W4200121631 hasConcept C82789193 @default.
• W4200121631 hasConcept C88879693 @default.
• W4200121631 hasConcept C90924648 @default.
• W4200121631 hasConceptScore W4200121631C120665830 @default.
• W4200121631 hasConceptScore W4200121631C121332964 @default.
• W4200121631 hasConceptScore W4200121631C121608353 @default.
• W4200121631 hasConceptScore W4200121631C126322002 @default.
• W4200121631 hasConceptScore W4200121631C134018914 @default.
• W4200121631 hasConceptScore W4200121631C151032500 @default.
• W4200121631 hasConceptScore W4200121631C188816634 @default.
• W4200121631 hasConceptScore W4200121631C2779901536 @default.
• W4200121631 hasConceptScore W4200121631C2780962732 @default.
• W4200121631 hasConceptScore W4200121631C44249647 @default.
• W4200121631 hasConceptScore W4200121631C526805850 @default.
• W4200121631 hasConceptScore W4200121631C555293320 @default.
• W4200121631 hasConceptScore W4200121631C61511704 @default.
• W4200121631 hasConceptScore W4200121631C71924100 @default.
• W4200121631 hasConceptScore W4200121631C72563966 @default.
• W4200121631 hasConceptScore W4200121631C82789193 @default.
• W4200121631 hasConceptScore W4200121631C88879693 @default.
• W4200121631 hasConceptScore W4200121631C90924648 @default.

• next